Your browser doesn't support javascript.
loading
Recombinant-follicle stimulating hormone is more effective than urinary human menopausal gonadotropin in ovarian hyperstimulation for assisted reproductive technology treatment.
Nakagawa, Koji; Ohgi, Shirei; Kojima, Rieko; Sugawara, Kana; Horikawa, Takashi; Ito, Megumu; Irahara, Minoaru; Saito, Hidekazu.
Afiliación
  • Nakagawa K; Division of Reproductive Medicine, Department of Perinetal Medicine and Maternal Care, National Center for Child Health and Development, Tokyo, and.
  • Ohgi S; Division of Reproductive Medicine, Department of Perinetal Medicine and Maternal Care, National Center for Child Health and Development, Tokyo, and.
  • Kojima R; Division of Reproductive Medicine, Department of Perinetal Medicine and Maternal Care, National Center for Child Health and Development, Tokyo, and.
  • Sugawara K; Division of Reproductive Medicine, Department of Perinetal Medicine and Maternal Care, National Center for Child Health and Development, Tokyo, and.
  • Horikawa T; Division of Reproductive Medicine, Department of Perinetal Medicine and Maternal Care, National Center for Child Health and Development, Tokyo, and.
  • Ito M; Division of Reproductive Medicine, Department of Perinetal Medicine and Maternal Care, National Center for Child Health and Development, Tokyo, and.
  • Irahara M; Department of Obstetrics and Gynecology, School of Medicine, the University of Tokushima, Tokushima, Japan.
  • Saito H; Division of Reproductive Medicine, Department of Perinetal Medicine and Maternal Care, National Center for Child Health and Development, Tokyo, and.
Reprod Med Biol ; 6(1): 27-32, 2007 Mar.
Article en En | MEDLINE | ID: mdl-29657551

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Reprod Med Biol Año: 2007 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Reprod Med Biol Año: 2007 Tipo del documento: Article